It remains unclear why some obese patients with NAFLD have only steatosis whereas others exhibit steatohepatitis, and alcohol consumption could have a different effect in these two conditions.

The trials identified no serious adverse effects, and patients tolerated a daily dosage of 1500 mg for 24 weeks.

Non-alcoholic steatohepatitis (NASH) is a condition characterized by accumulation of fat, inflammation and injury in liver cells in people who consume little or no alcohol. It is the progressive ...